APPLICATION
NDA206510
TYPE
NDA
ORIGINAL APPROVAL
2015-02-06
LATEST ACTION
2015-02-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DUTREBISDiscontinued
LAMIVUDINE 150MG, RALTEGRAVIR POTASSIUM EQ 300MG BASE · TABLET · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.